[go: up one dir, main page]

MX11090A - Procedimiento para la preparacion de pirazolo[3,4-d] pirimidinas. - Google Patents

Procedimiento para la preparacion de pirazolo[3,4-d] pirimidinas.

Info

Publication number
MX11090A
MX11090A MX1109088A MX1109088A MX11090A MX 11090 A MX11090 A MX 11090A MX 1109088 A MX1109088 A MX 1109088A MX 1109088 A MX1109088 A MX 1109088A MX 11090 A MX11090 A MX 11090A
Authority
MX
Mexico
Prior art keywords
radical
alkyl
denotes
pyrimidines
polysubstituted
Prior art date
Application number
MX1109088A
Other languages
English (en)
Inventor
Walter-Gunar Friebe
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of MX11090A publication Critical patent/MX11090A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Cosmetics (AREA)
MX1109088A 1987-04-15 1988-04-12 Procedimiento para la preparacion de pirazolo[3,4-d] pirimidinas. MX11090A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873712735 DE3712735A1 (de) 1987-04-15 1987-04-15 Neue pyrazolo(3,4-d)pyrimidine, verfahren zu ihrer herstellung und verwendung als arzneimittel

Publications (1)

Publication Number Publication Date
MX11090A true MX11090A (es) 1993-11-01

Family

ID=6325658

Family Applications (1)

Application Number Title Priority Date Filing Date
MX1109088A MX11090A (es) 1987-04-15 1988-04-12 Procedimiento para la preparacion de pirazolo[3,4-d] pirimidinas.

Country Status (20)

Country Link
US (1) US4904666A (es)
EP (1) EP0287907B1 (es)
JP (1) JPS63258880A (es)
KR (1) KR880012605A (es)
CN (1) CN88102247A (es)
AT (1) ATE79623T1 (es)
AU (1) AU613907B2 (es)
CA (1) CA1308713C (es)
DD (1) DD274030A5 (es)
DE (2) DE3712735A1 (es)
DK (1) DK196888A (es)
ES (1) ES2052629T3 (es)
FI (1) FI88163C (es)
HU (1) HU198493B (es)
IL (1) IL86013A (es)
MX (1) MX11090A (es)
NZ (1) NZ224219A (es)
PT (1) PT87229B (es)
SU (1) SU1701111A3 (es)
ZA (1) ZA882618B (es)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5047407A (en) * 1989-02-08 1991-09-10 Iaf Biochem International, Inc. 2-substituted-5-substituted-1,3-oxathiolanes with antiviral properties
US5256650A (en) * 1989-03-29 1993-10-26 Merrell Dow Pharmaceuticals Inc. Selective adenosine receptor agents
US5391739A (en) * 1989-03-29 1995-02-21 Merrell Dow Pharmaceuticals Inc. Selective adenosine receptor agents
ZA902280B (en) * 1989-03-29 1990-12-28 Merrell Dow Pharma Selective adenosine receptor agents
US5864033A (en) * 1989-09-15 1999-01-26 Metabasis Therapeutics, Inc. Adenosine kinase inhibitors
US5795977A (en) * 1989-09-15 1998-08-18 Metabasis Therapeutics, Inc. Water soluble adenosine kinase inhibitors
US5763597A (en) * 1989-09-15 1998-06-09 Metabasis Therapeutics, Inc. Orally active adenosine kinase inhibitors
US5721356A (en) * 1989-09-15 1998-02-24 Gensia, Inc. Orally active adenosine kinase inhibitors
US5674998A (en) * 1989-09-15 1997-10-07 Gensia Inc. C-4' modified adenosine kinase inhibitors
US5726302A (en) * 1989-09-15 1998-03-10 Gensia Inc. Water soluble adenosine kinase inhibitors
US5763596A (en) * 1989-09-15 1998-06-09 Metabasis Therapeutics, Inc. C-4' modified adenosine kinase inhibitors
TW370529B (en) 1992-12-17 1999-09-21 Pfizer Pyrazolopyrimidines
US5368857A (en) * 1993-11-15 1994-11-29 Elizabeth Arden Company, Division Of Conopco, Inc. Ceramide cosmetic compositions
US5646152A (en) * 1994-06-15 1997-07-08 Pfizer Inc. Methods of administering CRF antagonists
US5614530A (en) * 1995-03-10 1997-03-25 Sterling Winthrop Inc. Substituted N-arylmethyl and heterocyclmethyl-1H-pyrazolo[3,4-b]quinolin-4-amines and compositions and methods of use thereof
US6008226A (en) * 1995-03-10 1999-12-28 Sanofi-Synthelabo Substituted N-arylmethyl and heterocylylmethyl-1H-pyrazolo[3,4-b]quinolin-4-amines and compositions and methods of use thereof
PT778277E (pt) * 1995-12-08 2003-11-28 Pfizer Derivados heterociclicos substituidos como antagonistas do crf
US6992188B1 (en) 1995-12-08 2006-01-31 Pfizer, Inc. Substituted heterocyclic derivatives
US6051578A (en) * 1996-02-12 2000-04-18 Pfizer Inc. Pyrazolopyrimidines for treatment of CNS disorders
KR100517163B1 (ko) * 2000-02-10 2005-09-26 미쯔이카가쿠 가부시기가이샤 1-인산화 당유도체 아노머의 선택적인 제조방법 및뉴클레오사이드의 제조방법
KR100468352B1 (ko) * 2002-09-24 2005-01-27 한국과학기술연구원 신규 피라졸로피리미딘계 유도체, 그의 제조방법 및 이를 유효성분으로 하는 약학적 조성물
WO2005019222A1 (en) * 2003-08-15 2005-03-03 Merck & Co., Inc. 4-cycloalkylaminopyrazolo pyrimidine nmda/nr2b antagonists
WO2005019221A1 (en) * 2003-08-15 2005-03-03 Merck & Co., Inc. 4-cycloalkylaminopyrazolo pyrimidine nmda/nr2b antagonists
CA2575430A1 (en) * 2004-08-03 2006-02-16 Merck & Co., Inc. 1,3-disubstituted heteroaryl nmda/nr2b antagonists
US7777035B2 (en) * 2005-06-22 2010-08-17 Chemocentryx, Inc. Azaindazole compounds and methods of use
US20090252779A1 (en) * 2006-06-22 2009-10-08 Chemocentryx, Inc. Azaindazole compounds and methods of use
DE102006029074A1 (de) * 2006-06-22 2007-12-27 Friedrich-Schiller-Universität Jena 4-Amino-3-arylamino-6-arylpyrazolo[3,4-d]pyrimidin-Derivate, Verfahren zu ihrer Herstellung und deren Verwendung als antivirale Wirkstoffe
EP2766367B1 (de) 2011-10-14 2022-05-18 Scandion Oncology A/S 4-Amino-3-phenylamino-6-phenylpyrazolo[3,4-d]pyrimidin-Derivate zur Behandlung von viralen Infekten, insbesondere von Picornavirusinfektionen
DE102012004736A1 (de) 2011-10-20 2013-04-25 Dritte Patentportfolio Beteiligungsgesellschaft Mbh & Co.Kg 4-Amino-3-phenylamino-6-phenylpyrazolo[3,4-d]pyrimidin-Derivate und deren Verwendung als antivirale Wirkstoffe
US10647727B2 (en) * 2015-06-25 2020-05-12 Merck Sharp & Dohme Corp. Substituted pyrazolo/imidazolo bicyclic compounds as PDE2 inhibitors

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3551428A (en) * 1956-02-10 1970-12-29 Ciba Geigy Corp New 1- (or 2-) substituted 4-mercapto-pyrazolo(3,4-d)pyrimidines
DE1106331B (de) * 1958-05-30 1961-05-10 Ciba Geigy Verfahren zur Herstellung von Pyrazolo[3, 4-d]pyrimidinen
US3399196A (en) * 1959-01-22 1968-08-27 Ciba Geigy Corp Nu-substituted pyrazolo-pyrimidines
US3720674A (en) * 1970-09-02 1973-03-13 Squibb & Sons Inc 4-amino-1h-pyrazolo(3,4-d)pyrimidine derivatives
DE3739366A1 (de) * 1987-04-10 1988-10-27 Boehringer Mannheim Gmbh Desaza-purin-nucleosid-derivate, verfahren zu deren herstellung sowie deren verwendung bei der nucleinsaeure-sequenzierung sowie als antivirale mittel
US4885300A (en) * 1988-03-03 1989-12-05 Ortho Pharmaceutical Corporation 4-Substituted pyrazolo[3,4-D]pyrimidine derivatives

Also Published As

Publication number Publication date
FI881760A0 (fi) 1988-04-14
DE3873807D1 (de) 1992-09-24
HUT47578A (en) 1989-03-28
PT87229A (pt) 1988-05-01
FI88163C (fi) 1993-04-13
SU1701111A3 (ru) 1991-12-23
IL86013A (en) 1992-02-16
AU1450688A (en) 1988-10-20
ATE79623T1 (de) 1992-09-15
DK196888D0 (da) 1988-04-11
CN88102247A (zh) 1988-11-02
ZA882618B (en) 1988-10-17
ES2052629T3 (es) 1994-07-16
DK196888A (da) 1988-10-16
FI881760A (fi) 1988-10-16
US4904666A (en) 1990-02-27
CA1308713C (en) 1992-10-13
EP0287907A1 (de) 1988-10-26
DE3712735A1 (de) 1988-11-10
JPS63258880A (ja) 1988-10-26
KR880012605A (ko) 1988-11-28
IL86013A0 (en) 1988-09-30
FI88163B (fi) 1992-12-31
AU613907B2 (en) 1991-08-15
HU198493B (en) 1989-10-30
EP0287907B1 (de) 1992-08-19
NZ224219A (en) 1990-11-27
DD274030A5 (de) 1989-12-06
PT87229B (pt) 1992-08-31

Similar Documents

Publication Publication Date Title
MX11090A (es) Procedimiento para la preparacion de pirazolo[3,4-d] pirimidinas.
ATE90345T1 (de) Bis-naphthalimide, ihre herstellung und verwendung.
ES515081A0 (es) "procedimiento para la preparacion de derivados de 6-metilprednisolona".
DE3670841D1 (de) Pyridin-derivate, ihre herstellung und verwendung.
MX9200396A (es) Derivados de benciloxifenilo, procedimiento para su preparacion y composicion farmaceutica que los contiene.
SE7704609L (sv) Nya immunologiska hjelpforeningar och sett att framstella desamma
SE8700555D0 (sv) Purine derivatives, their production and medicaments containing them
ES8201955A1 (es) Un procedimiento de produccion de derivados del acido 2-hi- droxioxanilico
ES405213A1 (es) Procedimiento para la preparacion de nuevas pirido(3,2-d) pirimidinas.
MX170998B (es) Ligante hidraulico y procedimiento para su preparacion
ES504259A0 (es) Procedimiento para la obtencion de nuevos derivados de la tiazolo (3,2-a) pirimidina
DE3677857D1 (de) 2,5-dimethylpyrrolderivative, ihre herstellung und ihre verwendung.
ES2051778T3 (es) Procedimiento para preparar nuevas imidazo- y triazolotiadiazinas.
DE3269505D1 (en) Substituted 1-benzoyl-2-phenylimino-imidazolidines, their acid addition salts, process for their preparation and pharmaceutical compositions containing them
ES2011609A4 (es) Derivados acilados del acido bencilico para influir sobre el tono de la vejiga urinaria.
ES389458A1 (es) Procedimiento para la preparacion de pirido (2,3-d) pirimi-din-4-(3h)-onas.
FI882388A (fi) 4-substituerad 10-cyanmetylenpyrrolo /4,3-e/benzoazepin.
ES407775A1 (es) Procedimiento para la preparacion de sulfonilaminopirimidi-nas que disminuyen el azucar en la sangre.
YU78687A (sh) Postopek za pripravo derivatov purina
ATE78466T1 (de) 3-phenyl-2-styryl-pyrrolidine, ihre herstellung und verwendung.